GSK plc (LON:GSK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,983.00
-0.50 (-0.03%)
Jun 26, 2026, 5:12 PM GMT
GSK plc Employees
GSK plc had 66,841 employees as of December 31, 2025. The number of employees decreased by 1,788 or -2.61% compared to the previous year.
Employees
66,841
Change (1Y)
-1,788
Growth (1Y)
-2.61%
Revenue / Employee
490.42K GBP
Profits / Employee
87.21K GBP
Market Cap
79.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 66,841 | -1,788 | -2.61% |
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| Haleon | 24,535 |
| Smith & Nephew | 16,988 |
| Convatec Group | 10,910 |
| Hikma Pharmaceuticals | 9,400 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,796 |
| Oxford Nanopore Technologies | 1,316 |
GSK plc News
- 3 days ago - GSK Initiates Tender Offer for Nuvalent Shares - GuruFocus
- 3 days ago - GSK announces commencement of tender offer to acquire Nuvalent - TheFly
- 9 days ago - Spero: FDA Approves Utebzi, The First Oral Carbapenem For Complicated UTIs In Adults; Stock Up - Nasdaq
- 10 days ago - Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) - Business Wire
- 10 days ago - GSK Secures FDA Approval for Utebzi, First Oral Carbapenem for UTIs - GuruFocus
- 10 days ago - Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) - GlobeNewsWire
- 10 days ago - GSK Gains FDA Approval for New Oral Antibiotic Utebzi - GuruFocus
- 10 days ago - GSK, Spero Therapeutics announce FDA approval of Utebzi - TheFly